E
Emmanuel J. Favaloro
Researcher at Westmead Hospital
Publications - 731
Citations - 22370
Emmanuel J. Favaloro is an academic researcher from Westmead Hospital. The author has contributed to research in topics: Von Willebrand disease & Medicine. The author has an hindex of 60, co-authored 648 publications receiving 18261 citations. Previous affiliations of Emmanuel J. Favaloro include University of Verona & University of Sydney.
Papers
More filters
Journal ArticleDOI
2B or not 2B? Differential identification of type 2B, versus pseudo-von Willebrand disease.
TL;DR: The paper by Enayat et al (2006) who reported a large family case series of pseudo-von Willebrand disease (VWD) and concluded that this condition was probably under-diagnosed, and proposed that platelet aggregation in the presence of cryoprecipitate was a useful way to differentiate this disorder from type 2B VWD.
Journal ArticleDOI
Pearls and pitfalls in factor inhibitor assays.
TL;DR: Safeguards to reporting accurate factor inhibitor assays include initial characterization of the sample, using the Nijmegen modification, properly performing and interpreting an incubated mixing test in conjunction, and performing two dilutions for each dependent dilution in the factor inhibitor assay.
Journal ArticleDOI
Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.
Susan E. Rodgers,Nancy V. Lerda,Emmanuel J. Favaloro,Elizabeth M. Duncan,Graeme J. Casey,Diana Quinn,Mark Hertzberg,John V. Lloyd +7 more
TL;DR: In this study of patients from 5 specialist centers in Australia, type 2N vWD was found in 5 families and the 2-stage factor VIII assay was more useful as a screening test than the 1-stage assay, and both vWF-factor VIII binding assays were equally effective.
Journal ArticleDOI
The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours?
TL;DR: This review focuses on ongoing dilemmas and issues related to clinical and laboratory aspects of APS including diagnostic challenges posed by the protean clinical manifestations of AP s and potential pitfalls of applying the APS classification criteria as diagnostic criteria.
Journal ArticleDOI
Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests.
TL;DR: Mixing tests may have utility to help identify the pathway of follow‐up testing (ie, towards investigation of factor deficiencies, or else inhibitors), and are also useful for investigation of lupus anticoagulants (LA).